Cargando…
Comparative Immunogenomics of Canine Natural Killer Cells as Immunotherapy Target
Natural killer (NK) cells are key effectors of the innate immune system, but major differences between human and murine NK cells have impeded translation. Outbred dogs offer an important link for studies of NK biology and immunotherapy. We analyzed gene expression of putative NK populations from hea...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8476892/ https://www.ncbi.nlm.nih.gov/pubmed/34594320 http://dx.doi.org/10.3389/fimmu.2021.670309 |
_version_ | 1784575718642941952 |
---|---|
author | Gingrich, Alicia A. Reiter, Taylor E. Judge, Sean J. York, Daniel Yanagisawa, Mio Razmara, Aryana Sturgill, Ian Basmaci, Ugur Nur Brady, Rachel V. Stoffel, Kevin Murphy, William J. Rebhun, Robert B. Brown, C. Titus Canter, Robert J. |
author_facet | Gingrich, Alicia A. Reiter, Taylor E. Judge, Sean J. York, Daniel Yanagisawa, Mio Razmara, Aryana Sturgill, Ian Basmaci, Ugur Nur Brady, Rachel V. Stoffel, Kevin Murphy, William J. Rebhun, Robert B. Brown, C. Titus Canter, Robert J. |
author_sort | Gingrich, Alicia A. |
collection | PubMed |
description | Natural killer (NK) cells are key effectors of the innate immune system, but major differences between human and murine NK cells have impeded translation. Outbred dogs offer an important link for studies of NK biology and immunotherapy. We analyzed gene expression of putative NK populations from healthy dogs and dogs with naturally-occurring cancers examining differential gene expression across multiple conditions, including steady-state, in vitro activation with cytokines and co-culture, and in vivo activation with inhaled IL-15 in dogs receiving IL-15 immunotherapy. We also compared dog, mouse and human CD3-NKp46+ NK cells using a novel orthologous transcriptome. Distinct transcriptional profiles between NK populations exist between conditions and in vitro versus in vivo treatments. In cross-species analysis, canine NK cells were globally more similar to human NK cells than mice. These data define canine NK cell gene expression under multiple conditions and across species, filling an important gap in translational NK studies. |
format | Online Article Text |
id | pubmed-8476892 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-84768922021-09-29 Comparative Immunogenomics of Canine Natural Killer Cells as Immunotherapy Target Gingrich, Alicia A. Reiter, Taylor E. Judge, Sean J. York, Daniel Yanagisawa, Mio Razmara, Aryana Sturgill, Ian Basmaci, Ugur Nur Brady, Rachel V. Stoffel, Kevin Murphy, William J. Rebhun, Robert B. Brown, C. Titus Canter, Robert J. Front Immunol Immunology Natural killer (NK) cells are key effectors of the innate immune system, but major differences between human and murine NK cells have impeded translation. Outbred dogs offer an important link for studies of NK biology and immunotherapy. We analyzed gene expression of putative NK populations from healthy dogs and dogs with naturally-occurring cancers examining differential gene expression across multiple conditions, including steady-state, in vitro activation with cytokines and co-culture, and in vivo activation with inhaled IL-15 in dogs receiving IL-15 immunotherapy. We also compared dog, mouse and human CD3-NKp46+ NK cells using a novel orthologous transcriptome. Distinct transcriptional profiles between NK populations exist between conditions and in vitro versus in vivo treatments. In cross-species analysis, canine NK cells were globally more similar to human NK cells than mice. These data define canine NK cell gene expression under multiple conditions and across species, filling an important gap in translational NK studies. Frontiers Media S.A. 2021-09-14 /pmc/articles/PMC8476892/ /pubmed/34594320 http://dx.doi.org/10.3389/fimmu.2021.670309 Text en Copyright © 2021 Gingrich, Reiter, Judge, York, Yanagisawa, Razmara, Sturgill, Basmaci, Brady, Stoffel, Murphy, Rebhun, Brown and Canter https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Gingrich, Alicia A. Reiter, Taylor E. Judge, Sean J. York, Daniel Yanagisawa, Mio Razmara, Aryana Sturgill, Ian Basmaci, Ugur Nur Brady, Rachel V. Stoffel, Kevin Murphy, William J. Rebhun, Robert B. Brown, C. Titus Canter, Robert J. Comparative Immunogenomics of Canine Natural Killer Cells as Immunotherapy Target |
title | Comparative Immunogenomics of Canine Natural Killer Cells as Immunotherapy Target |
title_full | Comparative Immunogenomics of Canine Natural Killer Cells as Immunotherapy Target |
title_fullStr | Comparative Immunogenomics of Canine Natural Killer Cells as Immunotherapy Target |
title_full_unstemmed | Comparative Immunogenomics of Canine Natural Killer Cells as Immunotherapy Target |
title_short | Comparative Immunogenomics of Canine Natural Killer Cells as Immunotherapy Target |
title_sort | comparative immunogenomics of canine natural killer cells as immunotherapy target |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8476892/ https://www.ncbi.nlm.nih.gov/pubmed/34594320 http://dx.doi.org/10.3389/fimmu.2021.670309 |
work_keys_str_mv | AT gingrichaliciaa comparativeimmunogenomicsofcaninenaturalkillercellsasimmunotherapytarget AT reitertaylore comparativeimmunogenomicsofcaninenaturalkillercellsasimmunotherapytarget AT judgeseanj comparativeimmunogenomicsofcaninenaturalkillercellsasimmunotherapytarget AT yorkdaniel comparativeimmunogenomicsofcaninenaturalkillercellsasimmunotherapytarget AT yanagisawamio comparativeimmunogenomicsofcaninenaturalkillercellsasimmunotherapytarget AT razmaraaryana comparativeimmunogenomicsofcaninenaturalkillercellsasimmunotherapytarget AT sturgillian comparativeimmunogenomicsofcaninenaturalkillercellsasimmunotherapytarget AT basmaciugurnur comparativeimmunogenomicsofcaninenaturalkillercellsasimmunotherapytarget AT bradyrachelv comparativeimmunogenomicsofcaninenaturalkillercellsasimmunotherapytarget AT stoffelkevin comparativeimmunogenomicsofcaninenaturalkillercellsasimmunotherapytarget AT murphywilliamj comparativeimmunogenomicsofcaninenaturalkillercellsasimmunotherapytarget AT rebhunrobertb comparativeimmunogenomicsofcaninenaturalkillercellsasimmunotherapytarget AT brownctitus comparativeimmunogenomicsofcaninenaturalkillercellsasimmunotherapytarget AT canterrobertj comparativeimmunogenomicsofcaninenaturalkillercellsasimmunotherapytarget |